Categories: Post

Interview with the 2018 FNIH Lurie Prize in Biomedical Sciences Winner Zhijian ‘James’ Chen, PhD

Watch the full program here.

 

A recent breakthrough in our war against cancer is the development of therapies that harness our body’s immune system to seek out and destroy tumor cells. While such immunotherapies have significantly prolonged the life of some patients who had previously exhausted all treatment options, the majority of cancer patients still do not benefit from existing immunotherapies. Thus, there is an urgent need to devise new therapies that can benefit a larger population of cancer patients. A better understanding of the body’s immune system is also very important for the prevention and treatment of a growing list of autoimmune and inflammatory diseases, such as lupus, arthritis and neurodegenerative diseases. In these diseases, the immune system misfires and attacks our own tissues. Our immune system is also crucial for defending us from infections by a large variety of microbial pathogens, such as viruses, bacteria, and parasites.

c2st

Recent Posts

Rare Disease Research with Big Impact: What is Rett Syndrome?

While few have heard of this rare disease, the research behind Rett Syndrome is pushing…

6 days ago

AI in Medicine: Breakthrough Model Transforms Diagnosis

Imagine walking into a medical office and receiving a diagnosis in minutes rather than days.…

6 days ago

An Interview with Dr. Masahito Jimbo, an expert in patient – physician communication

Here's the What, Why, and Where from my interview with Dr. Mashito Jimbo. Dr. Jimbo…

6 days ago

Excavating the Field of Zooarchaeology: An Interview With Archaeologist Dr. Kate Bishop

Humans and animals have had complex relationships with one another throughout history. From domestication to…

1 week ago

Rare Disease, Real Results: The Team That’s Exploding Research for a Rare Brain Disorder

Imagine your child is sick, and no amount of doctor visits provides a satisfying answer…

2 weeks ago